Abstract. Introduction. RBMOnline - Vol 7. No Reproductive BioMedicine Online; on web 18 June 2003
|
|
- Eugene Dixon
- 5 years ago
- Views:
Transcription
1 RBMOnline - Vol 7. No Reproductive BioMedicine Online; on web 18 June 2003 Review Current status of preimplantation diagnosis for single gene disorders Dr Yury Verlinsky is a graduate, postgraduate and PhD of Kharkov University of the former USSR. His research interests include cytogenetics, embryology and prenatal and preimplantation genetics. He introduced polar body testing for preimplantation genetic diagnosis and developed the methods for karyotyping second polar body and individual blastomeres. He has published over 100 papers, as well as three books on preimplantation genetics. Dr Yury Verlinsky Dr Anver Kuliev received his PhD in Clinical Cytogenetics from Moscow Research Institute of Human Morphology in In 1979 he took the responsibility for the World Health Organization (WHO) s Hereditary Diseases Program in Geneva, where he developed the community-based programmes for prevention of genetic disorders and early approaches for prenatal diagnosis. He moved to the Reproductive Genetics Institute in 1990, where he heads the WHO Collaborating Center for Prevention of Genetic Disorders, and scientific research in prenatal and preimplantation genetics. He is an author on more than a hundred papers and nine books in the above areas, including three books in the field of Preimplantation Genetics. Dr Anver Kuliev Yury Verlinsky, Anver Kuliev 1 Reproductive Genetics Institute, 2825 North Halsted Street, Chicago, IL, USA 1 Correspondence: Tel: ; Fax: ; anverkuliev@hotmail.com or rgi@flash.net Abstract Preimplantation genetic diagnosis (PGD) has become an established procedure for avoiding the birth of affected children with single gene disorders. PGD is performed through polar body or blastomere biopsy, which has no deleterious effect on pre- and post-implantation development. This review describes the most recent developments and current changes in the spectrum of conditions for which PGD has been applied. The most recent applications of PGD include congenital malformations, blood group incompatibility and an increasing number of late onset disorders with genetic predisposition, all of which have not previously been diagnosed using PGD. Despite ethical concerns, PGD has also been used for preselection of unaffected and HLA matched embryos, and recently for preimplantation HLA matching without testing for the causative gene. This extends the practical value of PGD, with its utility being no longer limited to prevention of single gene disorders, by expanding it to treatment of siblings requiring stem cell transplantation. Keywords: blastomere biopsy, congenital malformations, ethics, HLA matching, late onset disorders, PGD Introduction Preimplantation genetic diagnosis (PGD) is a relatively new approach to detect genetic disorders before pregnancy, avoiding the need for prenatal diagnosis and abortion. It is based on testing of oocytes or embryos to pre-select and transfer only normal embryos back to the patient, achieving an unaffected pregnancy and the birth of a healthy child. PGD is performed either by testing single blastomeres removed from 8-cell preimplantation embryos, or by testing female gametes (Verlinsky and Kuliev, 2000). The latter is based on the removal and genetic analysis of the first and second polar bodies (PB1 and PB2), which represent the by-products of the first and second meiotic divisions. Because neither PB1 nor PB2 has any biological significance for embryo development, they may be removed and tested for their genetic content, in order to predict the resulting maternal contribution to the embryo. However, this approach cannot be applied to testing for paternally derived abnormalities and gender determination, which may be detected by genetic analysis of single blastomeres removed from cleavage stage embryos. Both methods, therefore, are complementary and may be applied 145
2 146 depending on the PGD objectives in each patient. More that 5000 PGD cycles have been performed, resulting in the birth of well over 1000 children (Verlinsky et al., 2003a). The overall experience of using PGD for single gene disorders presently exceeds 1000 cases, showing that it is an established alternative to traditional prenatal diagnosis, and may be reliably used as an integral part of genetic practices (IWGPG, 2001; Kuliev and Verlinsky, 2002; ESHRE PGD Consortium, 2002). Changing spectrum of PGD application The list of disorders, presently comprising more than 50 different conditions, for which PGD has been applied is being extended beyond the indications for prenatal diagnosis, although the most frequent ones are still cystic fibrosis and haemoglobin disorders (IWGPG, 2001; ESHRE PGD Consortium, 2002). Of approximately 400 PGD cycles for single gene disorders, almost half were performed for cystic fibrosis and haemoglobin disorders, followed by myotonic dystrophy and X-linked mental retardation (XMR1) (Verlinsky et al., unpublished data), similar to experience in other active centres (ESHRE PGD Consortium, 2002). As there have been many previous reports on PGD for different single gene disorders, as well as extensive reviews on the subject (Handyside et al., 1992; Sermon et al., 1997, 1999, 2000; Kuliev et al., 1998, 1999; Xu et al., 1998; Kanavakis et al., 1999; De Vos et al., 2000; Goossens et al., 2000; Carvalho et al., 2001; Daniels et al., 2001; Georgiou et al., 2001; Harper et al., 2002; Hellani et al., 2002; Stern et al., 2002), this review will be limited to the most recent developments and current changes in the spectrum of conditions for which PGD has been applied. Specific diagnosis for X-linked diseases More than half of PGD cases for single gene disorders, from the very beginning, have involved gender determination for X- linked conditions, using either polymerase chain reaction (PCR) or fluorescence in-situ hybridization (FISH) (IWGPG, 2001; ESHRE PGD Consortium, 2002). This was not only because the sequence information was not always available, but also because it was technically easier to identify female embryos by DNA analysis or FISH, despite the obvious cost of discarding 50% healthy male embryos. On the other hand, testing for X-linked genetic disorders may be entirely limited to oocytes, because the mutations involved are fully maternally derived. Therefore, testing of oocytes for maternally derived specific mutations makes it possible to avoid further testing of the resulting embryos, which may be transferred irrespective of gender or any contribution from the father. Initially, the technique was applied for ornithine transcarbamylase deficiency (OTC) (Verlinsky et al., 2000). It has since been extended to the specific diagnosis of other X- linked disorders (Verlinsky et al., 2002a), and currently comprises experience of specific diagnosis in 35 cycles performed for OTC, XMR1, myotubular myotonic dystrophy and X-linked hydrocephalus. This resulted in the transfer of 68 mutation-free embryos in 33 cycles, with 12 unaffected clinical pregnancies. Specific diagnosis for X-linked mutations has also been performed at the cleavage stage (Ray et al., 1999, 2000). The data demonstrate the clinical usefulness of specific polar body or blastomere testing for X-linked disorders as an alternative to PGD by gender determination. Couples with homozygous affected partner PGD has also been successfully used in couples with one homozygous or compound-heterozygous affected partner with thalassaemia or phenylketonuria (PKU) (Verlinsky and Kuliev, 2000; Verlinsky et al., 2001a). Although the risk of producing an affected child in such couples is 50%, irrespective of maternal or paternal affected status, the strategy of PGD in such cases will depend on whether the father or mother is affected. In one such case when the father was affected, PGD was concentrated on the preselection of mutation free oocytes, while in the other, with the mother affected, a cleavage stage PGD was required to identify those few embryos containing the normal gene. Testing is particularly complicated if the parents are carrying different mutations. In one such case performed for thalassaemia, the affected mother was double heterozygous (IVS I-110; IVS I-6), while the male partner was a heterozygous carrier of the third mutation (IVS II-745) (Verlinsky and Kuliev, 2000). This required a complex PGD design to exclude preferential amplification of each of the three alleles tested in biopsied blastomeres, as described also in PGD for PKU (Verlinsky et al., 2001a). In this case, the affected father was compound heterozygous for R408 and Y414C mutations in exon 12 of the phenylalanine hydroxylase (PAH) gene, and the carrier mother heterozygous for the R408W mutation in the same exon. PGD strategy was based on the pre-selection of the mutation-free oocytes using sequential PB1 and PB2 DNA analysis. Based on multiplex hemi-nested PCR analysis, four embryos resulting from the zygotes predicted to contain no mutant allele of the PAH gene were transferred, resulting in an unaffected twin pregnancy and the birth of the healthy twins. With improvements in treatment and extended life expectancy for many genetic disorders, an increasing number of couples with affected maternal or paternal partners may require PGD in order to have unaffected children. Cancer predisposition Cancer predisposition has not traditionally been considered as an indication for prenatal diagnosis, as this would lead to pregnancy termination, which is scarcely justifiable on the basis of genetic predisposition alone. On the other hand, the possibility of choosing embryos free of genetic predisposition for transfer would obviate the need for considering pregnancy termination, as only potentially normal pregnancies would be established. PGD for such conditions appears acceptable on ethical grounds, because only a limited number of the embryos available from hyperstimulation are selected for transfer. The first PGD for inherited cancer predisposition was performed for couples carrying p53 tumour suppressor gene
3 mutations, known to determine a strong predisposition to the majority of cancers. It resulted in a singleton pregnancy and the birth of a healthy child free from the mutation predisposing to Li Fraumeni syndrome (Verlinsky et al., 2001b). The couple presented with the paternally derived missense mutation due to transversion of G to A in exon 5 of the p53 tumour suppressor gene. The carrier was a 38-year-old proband with Li Fraumeni syndrome (LFS), diagnosed with rhabdomyosarcoma of the right shoulder at the age of 2 years, followed by right upper extremity amputation. At the age of 31 years, he was also diagnosed with a high-grade leiomyosarcoma of the bladder and underwent a radical cystoprostatectomy. His mother was diagnosed with leimyosarcoma at age 37 years. At present, PGD is also being used for other cancers, including familial adenomatous polyposis coli, Von Hippel Lindau syndrome, retinoblastoma, neurofibromatosis type I and II and familial posterior fossa brain tumour (Rechitsky et al., 2002). Overall, 20 PGD cycles have been performed for 10 couples, resulting in preselection and transfer of 40 mutation-free embryos, which yielded five unaffected clinical pregnancies and four healthy children born to date. Despite the controversy surrounding PGD use for late onset disorders, the data demonstrate the usefulness of this approach as the only acceptable option for at-risk couples to avoid the birth of children with inherited predisposition to cancer, and to have a healthy child. Other late-onset disorders with genetic predisposition One of the first experiences of PGD for late-onset disorders was for genetic predisposition to one of the forms of Alzheimers disease (AD) (Verlinsky et al., 2002b). This condition is caused by an autosomal dominant familial predisposition to a presenile form of dementia, determined by a nearly completely penetrant autosomal dominant mutation in the amyloid precursor protein (APP) gene, for which no treatment is available despite a possible predictive diagnosis. The 30-year-old woman had no signs of AD, but was a carrier of the V717L mutation, resulting from a G to C substitution in exon 17 of the APP gene. Predictive testing in the patient was performed because of early onset AD in her sister, who carried this mutation and developed symptoms of AD at the age of 38 years. This sister is still alive, but her cognitive problems progressed to the point that she was placed in an assisted living facility. Her father had died at age 42 years and had also a history of psychological difficulties and marked memory problems. V717L mutation was also detected in one of her brothers, who experienced mild short-term memory problems as early as 35 years of age, with a moderate decline in memory, new learning and sequential tracking in the next 2 3 years. The other family members, including one brother and two sisters, were asymptomatic, although predictive testing was performed only in the sisters, who appeared to be free from a mutation in the APP gene. PGD was performed by DNA analysis of PB1 and PB2, resulting in a singleton clinical pregnancy and birth of an unaffected child. It may be argued that PGD should not be provided for a patient who might not be able to raise her child into adulthood, but it was the patient s decision to undertake PGD, and it is arguably a better option than to reproduce without testing, with a high risk of having an affected child. PGD therefore provides a further option for patients who may wish to avoid transmission of the mutant gene predisposing to late onset disorders in their potential children. Because such diseases present beyond early childhood, and even later may not be expressed in 100% of cases, the application of PGD for this group of disorders is still controversial. However, for diseases with no current prospect for treatment, arising despite pre-symptomatic diagnosis and follow-up, PGD may be offered as the only solution for at-risk couples. One example of the application of PGD in a late onset disorder is that of Huntington disease (HD). Non-disclosure PGD has been considered for at-risk couples, and involves the transfer of disease-free embryos, while the prospective parents do not learn their own status (Stern et al., 2002). Parents receive no information about number of oocytes obtained after hormonal stimulation, number of embryos developed, and the number of embryos available for transfer. However, there might be no unaffected embryos for transfer, or no affected embryos can be found, suggesting that the parent is genetically normal. The other alternative in HD is exclusion-pgd testing, but embryos with a detected grandparental allele would be excluded from transfer, notwithstanding that only half of these embryos would contain the affected allele. However, some European centres prefer performing direct testing of embryos from known disease gene carriers (Sermon et al., 2001). Blood group incompatibility The first PGD for materno fetal incompatibility resulting in a healthy pregnancy was performed for Kell (K1) genotype, which is one the major antigenic systems in human red blood cells. It is comparable in importance to RhD, causing materno fetal incompatibility leading to severe haemolytic disease of the newborn (HDN) in sensitized mothers (Verlinsky et al., 2003c). The K1 allele is present in 9% of populations, in contrast to its highly prevalent allelic variant K2. The gene is located on chromosome 7 (7q33), consisting of 19 exons, with the only C to T base substitution in exon 6 in K1 compared with K2 antigen. In a pregnancy with a K1 fetus in a K2 mother, antibodies to K1 may develop, leading to materno fetal incompatibility causing severe HDN. Although prenatal diagnosis is available for identification of pregnancies at risk for HDN, this may not always prevent potential complications for the fetus, stillbirth or neonatal death. PGD is therefore a possible option for preventing both Kell and Rhesus haemolytic diseases. PGD for Kell disease was performed for two at-risk couples with a history of neonatal death in previous pregnancies due to HDN. The preselection and transfer of embryos free from the K1 allele of the KEL gene was possible in each case, yielding a clinical pregnancy and the birth of healthy twins, confirmed to be free of the K1 allele. A number of attempts have also been undertaken to perform PGD for Rhesus disease, although they have not yet resulted in 147
4 a clinical pregnancy (Van Den Veyver, 2000). Both Kell disease and Rhesus incompatibility are quite prevalent (approximately 15% frequency for RhD and 9% for KEL antigen), presenting a risk for alloimmunization that may lead to HDN in some at-risk couples. Therefore, PGD may be a useful option for these couples to avoid the establishment of a RhD or K1 pregnancy in sensitized mothers. Although at-risk pregnancies detected by prenatal diagnosis may be treated by intrauterine transfusion, potential complications for the fetus cannot be completely excluded even after this procedure. Pregnancy termination in such cases will also be unacceptable, as the antibodies to K1, for example, are developed in only 5% of persons exposed to incompatible blood. On the other hand, some at-risk couples have had such an unfortunate experience of HDN, resulting in neonatal death, that they regard PGD as their only option to plan another pregnancy. This makes PGD attractive for patients at risk for alloimmunization, although such conditions have rarely been an indication for prenatal diagnosis. Congenital malformations Congenital malformations are highly prevalent (29.3/1000 live births) and are usually sporadic. However, with progress of the Human Genome Project, an increasing number of inherited forms are being described, which, therefore, may be avoided through PGD. For example, Sonic Hedgehog (SHH) gene mutation, for which the first PGD was recently performed (Verlinsky et al., 2003b), causes failure of the cerebral hemispheres to separate into distinct left and right halves and leads to holoprosencephaly (HPE), which is one of the most common developmental anomalies of forebrain and mid-face. Although the majority of HPE are sporadic, familial cases are not rare, with clear autosomal dominant inheritance. Significant intrafamilial clinical variability of HPE, from alobar HPE and cyclopia, to cleft lip and palate, microcephaly, ocular hypertelorism, and even normal phenotype, suggests interaction of the SHH gene with other genes expressed during craniofacial development and the possible involvement of environmental factors. This may explain the fact that almost one-third of carriers of SHH mutations may be clinically unaffected. Therefore, even in familial cases, the detection of SHH mutations in prenatal diagnosis might not justify pregnancy termination, making PGD a more attractive option for couples at risk for producing children with HPE. In the case described (Verlinsky et al., 2003b), the couple presented for PGD because of the previous birth of two children with clinical signs of HPE. One, a female with severe HPE and cleft lip and palate, died shortly after birth. Both the child and the parents were chromosomally normal, but DNA analysis in the child s autopsy material demonstrated the presence of SHH nonsense mutation due to GAG TAG sequence change, leading to premature termination of the protein at position 256 (Glu256 stop). The same mutation was found in their 5-year-old son, who was born after a fullterm normal pregnancy. This child had less severe facial dysmorphisms, which included microcephaly, Rathke s pouch 148 Figure 1. PGD for Sonic Hedgehog (SHH) mutation: family pedigree. Upper panel: the father (I-1) has a gonadal mosaicism for SHH mutation, which is linked to 156 bp dinucleotide C-A repeat allele of D7S550 polymorphic marker, while the mother (I-2) is normal, with one normal allele linked to 158 bp repeat and the other to 138 bp repeat alleles. Lower panel: reproductive outcomes of this couple, including three previous pregnancies, one resulting in the birth of affected child with holoprosencephaly, carrying the mutant gene (lower left) (II-1), one in perinatal death (II-2), also carrying the mutant gene [lower middle (circle)], and one in a spontaneously aborted fetus with Turner syndrome (II-3), free from SHH mutation [lower middle (triangle)]. The lower right open circle (II-4) represents the outcome of preimplantation diagnosis, resulting in an unaffected clinical pregnancy and birth of a healthy child, following confirmation of mutation-free status by amniocentesis. Reprinted with permission, from Verlinsky et al. (2003b).
5 cyst, single central incisor and choanal stenosis. There was also clinodactyly of the fifth fingers and incurved fourth toes bilaterally. The child s growth was slow in the first 2 years, but since then, he has been maintaining reasonably good growth. PGD was performed by blastomere biopsy and multiplex nested PCR analysis, involving specific mutation testing simultaneously with linked marker analysis. Of nine tested embryos, four were free of the mutant gene, of which two were transferred back to the patient, resulting in a singleton pregnancy and birth of a healthy child following confirmation of the mutation free status by amniocentesis (Figure 1). A similar approach has been used for PGD of Crouson syndrome (Abou-Sleiman et al., 2002). The data suggest the clinical usefulness of PGD for familial cases of congenital malformations. Because of the high prevalence of congenital anomalies, the approach may have practical implications for at-risk couples as a preventive measure to be employed in genetic practice. Preimplantation HLA matching combined with causative gene test Preimplantation HLA matching was first introduced in combination with mutation analysis for Fanconi anaemia, with the objective of establishing an unaffected pregnancy yielding a potential donor progeny for transplantation in an affected sibling (Verlinsky et al., 2001c). This resulted in a clinical pregnancy and birth of an unaffected child, whose cord blood was transplanted to the affected sibling, saving her life. This strategy is unlikely to be clinically acceptable through traditional prenatal genetic diagnosis, because of possible clinical pregnancy termination after HLA matching. However, PGD for such purposes should be acceptable, because only a limited number of the embryos are usually pre-selected for transfer, which in this case will represent unaffected embryos with a perfect match for affected siblings in need of a transplant. Since the multiplex single cell PCR used in PGD presents the opportunity for combined PGD and HLA testing, it has become a useful way to pre-select an embryo which may be an HLA match to the affected sibling requiring stem cell transplantation. The method has currently been applied for HLA genotyping in two dozen cycles in combination with PGD for thalassaemia, Fanconi anaemia, hyper-immunoglobulin M syndrome, X- linked adrenoleukodystrophy and Wiscott Aldrich syndrome. The results confirm the usefulness of preimplantation HLA matching as part of PGD, with the prospect of applying this approach to other inherited conditions, also requiring an HLA compatible donor for bone marrow transplantation (Verlinsky et al., unpublished data). This provides a realistic option for couples desiring to avoid the birth of an affected child, together with the establishment of a healthy pregnancy, potentially providing an HLA match progeny for treatment of an affected sibling. Ethical issues The increasing use of PGD for late onset disorders with genetic predisposition, and preimplantation HLA typing to produce an HLA compatible donor to treat a family member requiring stem cell transplantation, raises important ethical issues (see Edwards et al., 2003). Although there is no actual difference in the application of PGD for the latter conditions, the controversy can be explained by the fact that in traditional prenatal diagnosis, if the fetus is found to carry the gene predisposing to late-onset disorder or to be HLA unmatched, the couple would have to make an extremely difficult decision regarding pregnancy termination, which could hardly be justified by such findings. Alternatively, PGD technology allows genetic testing of human eggs and embryos before pregnancy is established, making it completely realistic to establish only HLA matched or potentially normal pregnancies without genetic predisposition to late onset disorders. In any case, as seen from the above review, PGD is now becoming an established clinical option in reproductive medicine and is applied using separate consent forms and the research protocols approved by institutional ethics committees. The number of apparently healthy children born after PGD has passed its first thousand, showing that there is no evidence of any incurred adverse effect. However, these protocols would still require confirmatory chorionic villous sampling or amniocentesis and follow-up monitoring of safety and accuracy. Although PGD will help solve some longstanding ethical problems, such as the abortion issue (which will be avoided as a result of this new approach), others could become a serious obstacle, particularly those related to designer babies. These considerations are highly relevant to the subject of PGD, as well as to any other new methods, as further development of appropriate technology for controlling genetic disability takes place. References Abou-Sleiman PM, Apessos A, Harper JC et al Pregnancy following preimplantation genetic diagnosis for Crouson syndrome. Molecular and Human Reproduction 8, Carvalho F, Sousa M, Fernandes S et al Preimplantation genetic diagnosis for familial amyloidotic plyneuropathy (FAP). Prenatal Diagnosis 21, Daniels G, Pettigrew R, Thornhill A et al Six unaffected livebirths following preimplantation diagnosis for spinal muscular atrophy. Molecular and Human Reproduction 7, De Vos A, Sermon K, Van de Velde H et al Two pregnancies after preimplantation genetic diagnosis of ostegenesis imperfecta type I and type IV. Human Genetics 106, Edwards RG 2003 Ethics of preimplantation diagnosis: recordings from the Fourth International Symposium on Preimplantation Genetics. Reproductive BioMedicine Online 6, ESHRE Preimplantation Genetic Diagnosis Consortium 2002 Data Collection III, May Human Reproduction, 17, Georgiou I, Sermon K, Lissens W et al Preimplantation genetic diagnsis for spinal and bulbar muscular atrophy (SBMA). Human Genetics 108, Goossens V, Sermon K, Lissens W. et al Clinical application of preimplantation genetic diagnosis for cystic fibrosis. Prenatal Diagnosis 20, Handyside AH, Lesko JG, Tarin JJ et al Birth of a normal girl after in vitro fertilization and preimplantation diagnosis testing for cystic fibrosis. New England Journal of Medicine 327, Harper J, Wells D, Piyamongkol W et al Preimplantation genetic diagnosis for single gene disorders: experience with five single gene disorders. Prenatal Diagnosis 22, Hellani A, Lauge A, Ozand P et al Pregancy after preimplantation genetic diagnosis for ataxia telangectasia. 149
6 Molecular and Human Reproduction 8, International Working Group on Preimplantation Genetics (IWGPG) 2001 Preimplantation genetic diagnosis experience of three thousand clinical cycles. Report of the 11th Annual Meeting International Working Group on Preimlantation Genetics, in conjunction with 10th International Congress of Human Genetics, Vienna, May 15, Reproductive BioMedicine Online 3, Kanavakis E, Vrettou C, Palmer G et al Preimplantation genetic diagnosis in 10 couples at risk for transmitting betathalassemia major: clinical experience including the initiation of six singleton pregnancies. Prenatal Diagnosis 19, Kuliev A, Verlinsky Y 2002 Current features of preimplantation genetic diagnosis. Reproductive BioMedicine Online 5, Kuliev A, Rechitsky S, Verlinsky O et al Preimplantation diagnosis of thalassemias. Journal of Assisted Reproduction and Genetics 15, Kuliev A, Rechitsky S, Verlinsky O et al Birth of healthy children after reimplantation diagnosis of thalassemias. Journal of Assisted Reproduction and Genetics 16, Ray P, Harper J, Ao A et al Successful preimplantation genetic diagnosis for sex linked Lesch Nyhan syndrome using specific diagnosis. Prenatal Diagnosis 19, Ray PF, Gigarel N, Bonnefont JP et al First specific preimplantation genetic diagnosis for ornithine transcarbamylase deficiency. Prenatal Diagnosis 20, Rechitsky S, Verlinsky O, Chistokina A et al Preimplantation genetic diagnosis for cancer predisposition. Reproductive BioMedicine Online 5, Sermon K, Lissens W, Joris H et al Clinical application of preimplantation diagnosis for myotonic dystrophy. Prenatal Diagnosis 17, Sermon K, Lissens W, Messiaen L et al Preimplantation genetic diagnosis of Marfan syndrome with the use of fluorescent polymerase chain reaction and automated laser fluorescence DNA sequencer. Fertility and Sterility 71, Sermon K, Henderix P, Lissens W et al Preimplantation genetic diagnosis for medium-chain acyl-coa dehydrogenase (MCAD) deficiency. Molecular and Human Reproduction 16, Sermon K, Seneca S, De Rycke M et al PGD in the lab for triplet diseases myotonic dystrophy, Huntington s disease and Fragile-X syndrome. Molecular and Cellular Endocrinology 183, S77 S85. Stern HJ, Harton GL, Sisson ME et al Non-disclosing preimplantation genetic diagnosis for Huntington disease. Prenatal Diagnosis 22, Van Den Veyver IB 2000 Prenatal and preimplantation genetic diagnosis for rhd alloimmunization. 10th International Conference on Prenatal Diagnosis and Therapy. Barcelona (Spain), June 19 21, University of Barcelona, pp Verlinsky Y, Kuliev A 2000 Atlas of Preimplantation Genetic Diagnosis. Parthenon Publishing Group, London, New York. Verlinsky Y, Rechitsky S, Verlinsky O et al Preimplantation diagnosis for ornithine transcarbamylase deficiency. Reproductive BioMedicine Online 1, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2001a Preimplantation diagnosis for PKU. Fertility and Sterility 76, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2001b Preimplantation diagnosis for p53 tumor suppressor gene mutations. Reproductive BioMedicine Online 2, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2001c Preimplantation diagnosis for Fanconi anemia combined with HLA matching. Journal of the American Medical Association 285, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2002a Polar body based preimplantation diagnosis for X-linked genetic disorders. Reproductive BioMedicine Online 4, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2002b Preimplantation diagnosis for early onset Alzheimer disease caused by V717L mutation. Journal of the American Medical Association 287, Verlinsky Y, Cohen J, Munne S et al. 2003a The first thousand babies born after preimplantation genetic diagnosis. Fertility and Sterility, in press. Verlinsky Y, Rechitsky S, Verlinsky O et al. 2003b Preimplantation diagnosis for Sonic Hedgehog mutation causing familial holoprosencephaly. New England Journal of Medicine 348, Verlinsky Y, Rechitsky S, Verlinsky O et al. 2003c Preimplantation diagnosis for Kell genotype. Fertility and Sterility, in press. Xu K, Shi ZM, Veeck LL, Hughes MR, Rosenwaks Z 1999 First unaffected pregnancy using preimplantation genetic diagnosis for sickle cell disease. Journal of the American Medical Association 281, Received 4 April 2003; refereed 22 April 2003 ; accepted 25 April
Articles Polar body-based preimplantation diagnosis for X-linked disorders
RBMOnline - Vol 4. No 1. 38 42 Reproductive BioMedicine Online; www.rbmonline.com/article/384 on web 20 November 2001 Articles Polar body-based preimplantation diagnosis for X-linked disorders Dr Yury
More informationArticle Preimplantation diagnosis and HLA typing for haemoglobin disorders
RBMOnline - Vol 11. No 3. 2005 362-370 Reproductive BioMedicine Online; www.rbmonline.com/article/1853 on web 20 July 2005 Article Preimplantation diagnosis and HLA typing for haemoglobin disorders Dr
More informationIVF Michigan, Rochester Hills, Michigan, and Reproductive Genetics Institute, Chicago, Illinois
FERTILITY AND STERILITY VOL. 80, NO. 4, OCTOBER 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. CASE REPORTS Preimplantation
More informationPreimplantation Diagnosis for Sonic Hedgehog Mutation Causing Familial Holoprosencephaly
The new england journal of medicine brief report Preimplantation Diagnosis for Sonic Hedgehog Mutation Causing Familial Holoprosencephaly Yury Verlinsky, Ph.D., Svetlana Rechitsky, Ph.D., Oleg Verlinsky,
More informationAbstract. Introduction. RBMOnline - Vol 8. No Reproductive BioMedicine Online; on web 10 December 2003
RBMOnline - Vol 8. No 2. 224-228 Reproductive BioMedicine Online; www.rbmonline.com/article/1133 on web 10 December 2003 Article Preimplantation genetic diagnosis for early-onset torsion dystonia Dr Svetlana
More informationArticle Pre-embryonic diagnosis for Sandhoff disease
RBMOnline - Vol 12. No 3. 2006 328-333 Reproductive BioMedicine Online; www.rbmonline.com/article/2100 on web 9 January 2006 Article Pre-embryonic diagnosis for Sandhoff disease Dr Anver Kuliev received
More informationPREIMPLANTATION GENETIC DIAGnosis
ORIGINAL CONTRIBUTION Preimplantation HLA Testing Yury Verlinsky, PhD Svetlana Rechitsky, PhD Tatyana Sharapova, MS Randy Morris, MD Mohammed Taranissi, MD Anver Kuliev, MD, PhD For editorial comment see
More informationPreimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky
Preimplantation diagnosis: a realistic option for assisted reproduction and genetic practice Anver Kuliev and Yury Verlinsky Purpose of review Preimplantation genetic diagnosis (PGD) allows genetically
More informationAbstract. Introduction. RBMOnline - Vol 9. No Reproductive BioMedicine Online; on web 23 June 2004
RBMOnline - Vol 9. No 2. 2004 210-221 Reproductive BioMedicine Online; www.rbmonline.com/article/1401 on web 23 June 2004 Article Preimplantation genetic diagnosis with HLA matching Dr Svetlana Rechitsky
More informationETHICAL ISSUES IN REPRODUCTIVE MEDICINE
ETHICAL ISSUES IN REPRODUCTIVE MEDICINE Medicine was, in its history, first of all curative, then preventive and finally predictive, whereas today the order is reversed: initially predictive, then preventive
More informationPGD: FROM DIAGNOSIS TO THERAPY
PGD: FROM DIAGNOSIS TO THERAPY MC Magli, L. Gianaroli Reproductive Medicine Unit - Via Mazzini, 2-438 Bologna www.sismer.it Since the birth of the first baby conceived using IVF techniques in 978 over
More informationAn Update on PGD: Where we are today
An Update on PGD: Where we are today Joyce Harper UCL Centre for PG&D and CRGH Institute for Womens Health University College London Overview What is PGD/PGS How we do it Disadvantages and advantages Future
More informationGenomics and Genetics in Healthcare. By Mary Knutson, RN, MSN
Genomics and Genetics in Healthcare By Mary Knutson, RN, MSN Clinical Objectives Understand the importance of genomics to provide effective nursing care Integrate genetic knowledge and skills into nursing
More informationPreimplantation Genetic Testing
Protocol Preimplantation Genetic Testing (40205) Medical Benefit Effective Date: 01/01/14 Next Review Date: 09/14 Preauthorization No Review Dates: 09/11, 09/12, 09/13 The following Protocol contains medical
More informationC H A P T E R Molecular Genetics Techniques for Preimplantation Genetic Diagnosis
Author, please provide citation of references 82, 83 in the text C H A P T E R Molecular Genetics 16 Techniques for Preimplantation Genetic Diagnosis Francesco Fiorentino, Gayle M Jones Introduction HISTORICAL
More informationPractical Preimplantation Genetic Diagnosis
Practical Preimplantation Genetic Diagnosis Yury Verlinsky and Anver Kuliev Practical Preimplantation Genetic Diagnosis With 125 Figures Yury Verlinsky, PhD Anver Kuliev, MD, PhD Reproductive Genetics
More informationMedical Policy Preimplantation Genetic Testing
Medical Policy Preimplantation Genetic Testing Document Number: 004 Commercial* and Connector/ Qualified Health Plans Authorization required X No notification or authorization Not covered * Not all commercial
More informationChapter 4 PEDIGREE ANALYSIS IN HUMAN GENETICS
Chapter 4 PEDIGREE ANALYSIS IN HUMAN GENETICS Chapter Summary In order to study the transmission of human genetic traits to the next generation, a different method of operation had to be adopted. Instead
More informationProblem Challenge Need. Solution Innovation Invention
Problem Challenge Need Solution Innovation Invention Tubal Infertility In-vitro Fertilisation Steptoe and Edwards Birth after the reimplantation of a human embryo. Lancet 1978 Louise Brown, 25. Juli 1978
More informationReproductive Technology, Genetic Testing, and Gene Therapy
Michael Cummings Chapter 16 Reproductive Technology, Genetic Testing, and Gene Therapy David Reisman University of South Carolina 16.1 Infertility Is a Common Problem In the US, about 13% of all couples
More informationThe Ethical Implications of Preimplantation Genetic Diagnosis (PGD)
The Ethical Implications of Preimplantation Genetic Diagnosis (PGD) "The great challenge to mankind today is not only how to create, but to know when to stop creating." Lord Emmanuel Jacobvitz, former
More informationMULTIPLE CHOICE QUESTIONS
SHORT ANSWER QUESTIONS-Please type your awesome answers on a separate sheet of paper. 1. What is an X-linked inheritance pattern? Use a specific example to explain the role of the father and mother in
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationOriginal Policy Date
MP 2.04.76 Genetic Counseling Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Created Local Policy/ 12:2013 Return to Medical Policy Index Disclaimer
More informationClassifications of genetic disorders disorders
Classifications of genetic disorders Dr. Liqaa M. Sharifi Human diseases in general can roughly be classified in to: 1-Those that are genetically determined. 2-Those that are almost entirely environmentally
More informationOriginal Policy Date
MP 2.04.77 Preimplantation Genetic Testing Medical Policy Section OB/Gyn/Reproduction Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013 Return to
More informationPre-Implantation Genetic Diagnosis. Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN
Pre-Implantation Genetic Diagnosis Bradley Kalinsky, MD Amanda Kalinsky, RN, BSN Our Clinical Vignette A young couple in the mid-to-late twenties presents to your clinic to discuss having children. The
More informationAgro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17
Agro/Ansc/Bio/Gene/Hort 305 Fall, 2017 MEDICAL GENETICS AND CANCER Chpt 24, Genetics by Brooker (lecture outline) #17 INTRODUCTION - Our genes underlie every aspect of human health, both in function and
More informationPolar Body Approach to PGD. Anver KULIEV. Reproductive Genetics Institute
Polar Body Approach to PGD Anver KULIEV Reproductive Genetics Institute DISCLOSURE othing to disclose 14 History of Polar Body Approach 14 First proposed in World Health Organization s Document Perspectives
More informationBasic Definitions. Dr. Mohammed Hussein Assi MBChB MSc DCH (UK) MRCPCH
Basic Definitions Chromosomes There are two types of chromosomes: autosomes (1-22) and sex chromosomes (X & Y). Humans are composed of two groups of cells: Gametes. Ova and sperm cells, which are haploid,
More informationGenetic screening. Martin Delatycki
7 Genetic screening Martin Delatycki Case study 1 Vanessa and John are planning a family. They see their general practitioner and ask whether they should have any tests prior to falling pregnant to maximise
More informationPGS & PGD. Preimplantation Genetic Screening Preimplantation Genetic Diagnosis
1 PGS & PGD Preimplantation Genetic Screening Preimplantation Genetic Diagnosis OUR MISSION OUR MISSION CooperGenomics unites pioneering leaders in reproductive genetics, Reprogenetics, Recombine, and
More informationLab Activity 36. Principles of Heredity. Portland Community College BI 233
Lab Activity 36 Principles of Heredity Portland Community College BI 233 Terminology of Chromosomes Homologous chromosomes: A pair, of which you get one from mom, and one from dad. Example: the pair of
More informationArticle Preimplantation HLA typing with aneuploidy testing
RBMOnline - Vol 12. No 1. 2006 89-100 Reproductive BioMedicine Online; www.rbmonline.com/article/1993 on web 10 November 2005 Article Preimplantation HLA typing with aneuploidy testing Dr Svetlana Rechitsky
More informationNon-Mendelian inheritance
Non-Mendelian inheritance Focus on Human Disorders Peter K. Rogan, Ph.D. Laboratory of Human Molecular Genetics Children s Mercy Hospital Schools of Medicine & Computer Science and Engineering University
More informationA Stepwise Approach to Embryo Selection and Implantation Success
Precise Genetic Carrier Screening An Overview A Stepwise Approach to Embryo Selection and Implantation Success Put today s most advanced genetic screening technology to work for you and your family s future.
More informationHuman inherited diseases
Human inherited diseases A genetic disorder that is caused by abnormality in an individual's DNA. Abnormalities can range from small mutation in a single gene to the addition or subtraction of a whole
More informationCh 7 Extending Mendelian Genetics
Ch 7 Extending Mendelian Genetics Studying Human Genetics A pedigree is a chart for tracing genes in a family. Used to determine the chances of offspring having a certain genetic disorder. Karyotype=picture
More informationUnit 3: DNA and Genetics Module 9: Human Genetics
Unit 3: DNA and Genetics Module 9: Human Genetics NC Essential Standard: 3.2 Understand how the environment, and /or the interaction of alleles, influences the expression of genetic traits. 3.3.3 Evaluate
More informationGenetic Assessment and Counseling
Genetic Assessment and Counseling Genetic counseling is the communication of information and advice about inherited conditions and a person seeking such advice is called a consultand. This process includes
More informationGenetic Diseases. SCPA202: Basic Pathology
Genetic Diseases SCPA202: Basic Pathology Amornrat N. Jensen, Ph.D. Department of Pathobiology School of Science, Mahidol University amornrat.nar@mahidol.ac.th Genetic disease An illness caused by abnormalities
More informationPreimplantation genetic diagnosis
Preimplantation genetic diagnosis Borut Peterlin Clinical institute of medical genetics, University Medical Centre Ljubljana Outline of the presentation Primary prevention of genetic diseases Motivation
More informationThe preventative role of preimplantation genetic diagnosis?
The preventative role of preimplantation genetic diagnosis? Alison Lashwood Consultant Genetic Counsellor & Clinical Lead in PGD PGDGenetics@gstt.nhs.uk www.pgd.org.uk Where it all starts.. Kay & John
More informationWhat is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD
What is New in Genetic Testing Steven D. Shapiro MS, DMD, MD 18th Annual Primary Care Symposium Financial and Commercial Disclosure I have a no financial or commercial interest in my presentation. 2 Genetic
More informationGenetic counselling in PGD
Genetic counselling in PGD Sérgio Castedo Serviço de Genética Faculdade de Medicina do Porto scastedo@netcabo.pt Disclosure of interests Sérgio Castedo is the CEO of GDPN, a private genetics diagnostic
More informationPedigree Analysis. Genetic disorders. Dominant inheritance. Recessive inheritance. Autosomal vs. sex-linked traits. X-linked recessive inheritance
Genetic disorders 4.2 Errors During Meiosis 5.3 Following Patterns of Human nheritance Pedigree Analysis 2005 Lee Bardwell Autosomal vs. sex-linked traits Autosomal traits are caused by genes on autosomes
More informationCHROMOSOMAL NUMERICAL ABERRATIONS INSTITUTE OF BIOLOGY AND MEDICAL GENETICS OF THE 1 ST FACULTY OF MEDICINE
CHROMOSOMAL NUMERICAL ABERRATIONS INSTITUTE OF BIOLOGY AND MEDICAL GENETICS OF THE 1 ST FACULTY OF MEDICINE CHROMOSOMAL ABERRATIONS NUMERICAL STRUCTURAL ANEUPLOIDY POLYPLOIDY MONOSOMY TRISOMY TRIPLOIDY
More informationPGD for inherited cardiac diseases
Reproductive Bioedicine Online (2012) 24, 443 453 www.sciencedirect.com www.rbmonline.com ARTICLE for inherited cardiac diseases Anver Kuliev *, Ekaterina Pomerantseva, Dana Polling, Oleg Verlinsky, Svetlana
More informationGenetics and Reproductive Options for SMA Families Annual SMA Conference Dallas, Texas Friday, June 15, 2017
Genetics and Reproductive Options for SMA Families 2018 Annual SMA Conference Dallas, Texas Friday, June 15, 2017 Part 1: SMA and Genetics Louise R Simard, PhD Part 2: SMA Carrier Screening Melissa Gibbons,
More informationUnifactorial or Single Gene Disorders. Hanan Hamamy Department of Genetic Medicine and Development Geneva University Hospital
Unifactorial or Single Gene Disorders Hanan Hamamy Department of Genetic Medicine and Development Geneva University Hospital Training Course in Sexual and Reproductive Health Research Geneva 2011 Single
More informationPreimplantation Genetic Diagnosis (PGD) in Western Australia
Preimplantation Genetic Diagnosis (PGD) in Western Australia Human somatic cells have 46 chromosomes each, made up of the 23 chromosomes provided by the egg and the sperm cell from each parent. Each chromosome
More informationLesson Overview. Human Chromosomes. Lesson Overview. Human Chromosomes
Lesson Overview Karyotypes A genome is the full set of genetic information that an organism carries in its DNA. A study of any genome starts with chromosomes, the bundles of DNA and protein found in the
More informationPre-implantation genetic diagnosis (pgd) for heart disease determined by genetic factors
Interventional Cardiology Pre-implantation genetic diagnosis (pgd) for heart disease determined by genetic factors The application of PGD has currently been extended to an increasing number of common disorders
More informationPreimplantation genetic diagnosis: polar body and embryo biopsy
Human Reproduction, Vol. 15, (Suppl. 4), pp. 69-75, 2000 Preimplantation genetic diagnosis: polar body and embryo biopsy Luca Gianaroli SISMER, Via Mazzini 12, 40138 Bologna, Italy Scientific Director
More information15/12/2011. You and your genes (OCR)
You and your genes (OCR) Variation Variation is the name given to differences between individuals of the SAME species. Variation is due to GENETIC or ENVIRONMENTAL causes. For example, consider dogs: 1)
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationSingle Gene (Monogenic) Disorders. Mendelian Inheritance: Definitions. Mendelian Inheritance: Definitions
Single Gene (Monogenic) Disorders Mendelian Inheritance: Definitions A genetic locus is a specific position or location on a chromosome. Frequently, locus is used to refer to a specific gene. Alleles are
More informationCase report Pregnancy after preimplantation genetic diagnosis for brachydactyly type B
RBMOnline - Vol 18 No 1. 2009 127-131 Reproductive BioMedicine Online; www.rbmonline.com/article/3583 on web 21 November 2008 Case report Pregnancy after preimplantation genetic diagnosis for brachydactyly
More informationUnit 2 Physiology and Health Part (a) The Reproductive System HOMEWORK BOOKLET
Unit 2 Physiology and Health Part (a) The Reproductive System HOMEWORK BOOKLET Name: Homework Date Due Mark % Key Area 1 The structure and function of reproductive organs Key Area 2 Hormonal control of
More informationCorporate Medical Policy
Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018
More informationLab Activity Report: Mendelian Genetics - Genetic Disorders
Name Date Period Lab Activity Report: Mendelian Genetics - Genetic Disorders Background: Sometimes genetic disorders are caused by mutations to normal genes. When the mutation has been in the population
More informationWhat is the relationship between genes and chromosomes? Is twinning genetic or can a person choose to have twins?
WHAT WILL YOU KNOW? What is the relationship between genes and chromosomes? Is twinning genetic or can a person choose to have twins? How could a person have the gene for something that is never apparent?
More informationAtlas of Genetics and Cytogenetics in Oncology and Haematology
Atlas of Genetics and Cytogenetics in Oncology and Haematology Genetic Counseling I- Introduction II- Motives for genetic counseling requests II-1. Couple before reproduction II-2. Couple at risk III-
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationGenetic Disorders. PART ONE: Detecting Genetic Disorders. Amniocentesis Chorionic villus sampling Karyotype Triple Screen Blood Test
Genetic Disorders PART ONE: Detecting Genetic Disorders Amniocentesis Chorionic villus sampling Karyotype Triple Screen Blood Test Amniocentesis A technique for determining genetic abnormalities in a fetus
More informationChildhood Leukemia Causes, Risk Factors, and Prevention
Childhood Leukemia Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for childhood
More informationUnit 3: DNA and Genetics Module 9: Human Genetics
Unit 3: DNA and Genetics Module 9: Human Genetics NC Essential Standard: 3.2.3 Explain how the environment can influence expression of genetic traits 3.3.3 Evaluate ethical issues surrounding the use of
More informationHuman Genetic Diseases (non mutation)
mutation) Pedigrees mutation) 1. Autosomal recessive inheritance: this is the inheritance of a disease through a recessive allele. In order for the person to have the condition they would have to be homozygous
More informationThe study of hereditary traits
Hereditary traits The study of hereditary traits Traits determined by phenotypic expression of one or several genes, ± interaction with environment factors; The weight of hereditary factors in phenotype
More informationCLINICAL GENETICS 1. GENERAL ASPECTS OF THE SPECIALISATION. 1.1 Purpose of the specialisation
CLINICAL GENETICS 1. GENERAL ASPECTS OF THE SPECIALISATION 1.1 Purpose of the specialisation The specialisation is an education and learning process in which trainee specialists (residents) acquire theoretical
More informationSEX-LINKED INHERITANCE. Dr Rasime Kalkan
SEX-LINKED INHERITANCE Dr Rasime Kalkan Human Karyotype Picture of Human Chromosomes 22 Autosomes and 2 Sex Chromosomes Autosomal vs. Sex-Linked Traits can be either: Autosomal: traits (genes) are located
More informationGenetics. by their offspring. The study of the inheritance of traits is called.
Genetics DNA contains the genetic code for the production of. A gene is a part of DNA, which has enough bases to make for many different proteins. These specific proteins made by a gene decide the of an
More informationProblem set questions from Final Exam Human Genetics, Nondisjunction, and Cancer
Problem set questions from Final Exam Human Genetics, Nondisjunction, and ancer Mapping in humans using SSRs and LOD scores 1. You set out to genetically map the locus for color blindness with respect
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More information40 Bell Work Week 8 5/12 41 Genetic Notes 5/12 42 Bill Nye Video & Questions 5/12
40 Bell Work Week 8 5/12 41 Genetic Notes 5/12 42 Bill Nye Video & Questions 5/12 1. I am available after school on Wed. and Thurs. this week. 2. Quiz Friday over genetic material 3. Last day to turn in
More informationLecture 17: Human Genetics. I. Types of Genetic Disorders. A. Single gene disorders
Lecture 17: Human Genetics I. Types of Genetic Disorders A. Single gene disorders B. Multifactorial traits 1. Mutant alleles at several loci acting in concert C. Chromosomal abnormalities 1. Physical changes
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationState the number of chromosomes which would be present in the cells labelled A, Band C.
M N&ll!Iif..t _ class lviarks DO NOT WRITE IN TIllS MARGIN. The diagram below represents stages in the production of human sperm. (a) Name the type of cell division that produces sex cells. (b) State the
More informationSex Determination. Male = XY. Female = XX. 23 pairs of chromosomes (22 autosomes/body chromosomes, 1 sex)
Sex Determination Male = XY Female = XX 23 pairs of chromosomes (22 autosomes/body chromosomes, 1 sex) X chromosome----->large, rod shaped Y chromosome-----> smaller Mating of male & female XY x XX X Y
More informationChromosomal Aneuploidy
The Many Advantages of Trophectoderm Biopsy Compared to Day 3 Biopsy for Pre- Implantation Genetic Screening (PGS) Mandy Katz-Jaffe, PhD Chromosomal Aneuploidy Trisomy 21 Fetus Aneuploidy is the most common
More informationPedigree Construction Notes
Name Date Pedigree Construction Notes GO TO à Mendelian Inheritance (http://www.uic.edu/classes/bms/bms655/lesson3.html) When human geneticists first began to publish family studies, they used a variety
More informationOver. years. dedicated to women s health
Over 80 years dedicated to women s health At Women s Health Dexeus we accompany our patients through the different stages of their lives infancy, adolescence, youth, maternity, menopause and active ageing
More information2. Circle the genotypes in the table that are homozygous. Explain how the two different homozygous genotypes result in different phenotypes.
Genetics Supplement (These supplementary modules, a Genetics Student Handout, and Teacher Preparation Notes with background information are available at http://serendip.brynmawr.edu/sci_edu/waldron/#genetics.
More informationGene Expression and Mutation
Gene Expression and Mutation GENE EXPRESSION: There are hormonal and environmental factors that may cause the expression of some genetic information. Some examples are: 1. The two- colour pattern of some
More informationIntroduction to Evaluating Hereditary Risk. Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center
Introduction to Evaluating Hereditary Risk Mollie Hutton, MS, CGC Certified Genetic Counselor Roswell Park Comprehensive Cancer Center Objectives Describe genetic counseling and risk assessment Understand
More informationA. Incorrect! Cells contain the units of genetic they are not the unit of heredity.
MCAT Biology Problem Drill PS07: Mendelian Genetics Question No. 1 of 10 Question 1. The smallest unit of heredity is. Question #01 (A) Cell (B) Gene (C) Chromosome (D) Allele Cells contain the units of
More informationWhat we know about Li-Fraumeni syndrome
What we know about Li-Fraumeni syndrome Dr Helen Hanson Consultant in Cancer Genetics St Georges Hospital, South-West Thames Regional Genetics Service History of LFS 1969 Li and Fraumeni describe four
More information7.1 Molecular Characterization of Fragile X Syndrome
7 GENETIC DISORDERS Advances in knowledge of molecular genetics, cytogenetics and biochemical genetics have led to availability of diagnostic tests for various genetic disorders. The most important application
More informationGenetics. the of an organism. The traits of that organism can then be passed on to, on
Genetics DNA contains the genetic code for the production of. A gene is a segment of DNA, which consists of enough bases to code for many different proteins. The specific proteins produced by a gene determine
More informationReview Packet for Genetics and Meiosis
Name: Date: Block: 1 Review Packet for Genetics and Meiosis Directions: Answer the questions and where indicated, draw a Punnett square and show all work! 1. Who was Gregor Mendel? Where did he live and
More informationGenetic Testing and Policies ASLME Public Health Conference September 14, 2010
Genetic Testing and Policies ASLME Public Health Conference September 14, 2010 Judith Daar Associate Dean, Whittier Law School Clinical Professor, UCI College of Medicine Genetics and Society Genetic
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationThe University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Genetics
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Genetics 1. GOAL: Understand the role of the pediatrician in preventing genetic disease, and in counseling and screening
More informationScreening for haemoglobinopathies in pregnancy
Policy Statement All Southern Health patients will receive clinical care that reflects best practice and is based on the best available evidence. Index of chapters within background 1. Prevalence of haemoglobinopathies
More informationPATIENT EDUCATION. carrier screening INFORMATION
PATIENT EDUCATION carrier screening INFORMATION carrier screening AT A GLANCE Why is carrier screening recommended? Carrier screening is one of many tests that can help provide information to you and your
More informationNOTES: : HUMAN HEREDITY
NOTES: 14.1-14.2: HUMAN HEREDITY Human Genes: The human genome is the complete set of genetic information -it determines characteristics such as eye color and how proteins function within cells Recessive
More informationPreimplantation genetic diagnosis: current status and new developments
Human Reproduction vol.12 no.8 pp.1756 1761, 1997 Preimplantation genetic diagnosis: current status and new developments Willy Lissens 1 and Karen Sermon However, owing to the risk of misdiagnosis (one
More informationGenetics Review and Reproductive Options in Kennedy Disease
+ Alice Schindler, MS, CGC Genetic Counselor, NIH/NINDS/Neurogenetics Branch Heather Montie, PhD, Assistant Professor Department of Bio-Medical Sciences Philadelphia College of Osteopathic Medicine Annual
More informationThe role of the PGD Consortium. Overview. ESHRE PGD Consortium - Aims
The role of the PGD Consortium Joyce Harper Chair of the ESHRE PGD Consortium Overview Aims Membership Data Pregnancies Guidelines Training courses/education/post congress workshops Working groups PGS
More informationPreimplantation Genetic Diagnosis and Savior Siblings. Brooke Csu kas
Preimplantation Genetic Diagnosis and Savior Siblings Brooke Csu kas Preimplantation Genetic Diagnosis and Savior Siblings An Honors Thesis - HONRS 499 By Brooke Csukas Thesis Advisor Dr. Jennifer Metzler
More information